Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia

Treatment of chronic myeloid leukemia (CML) with tyrosine kinase inhibitors has advanced to a stage where many patients achieve very low or undetectable levels of disease. Remarkably, some of these patients remain in sustained remission when treatment is withdrawn, suggesting that they may be at lea...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Leukemia
Huvudupphovsmän: Cross, N C P, White, H E, Colomer, D, Ehrencrona, H, Foroni, L, Gottardi, E, Lange, T, Lion, T, Machova Polakova, K, Dulucq, S, Martinelli, G, Oppliger Leibundgut, E, Pallisgaard, N, Barbany, G, Sacha, T, Talmaci, R, Izzo, B, Saglio, G, Pane, F, Müller, M C, Hochhaus, A
Materialtyp: Artigo
Språk:Inglês
Publicerad: Nature Publishing Group 2015
Ämnen:
Review
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4430701/
https://ncbi.nlm.nih.gov/pubmed/25652737
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2015.29
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk